OTCMKTS:BTCY Biotricity Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Biotricity Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.16 +0.09 (+8.41 %) (As of 09/24/2020 12:00 AM ET) Add Compare Share Today's Range$1.03Now: $1.16▼$1.1650-Day Range$1.07MA: $1.27▼$1.5052-Week Range$0.26Now: $1.16▼$2.21Volume26,371 shsAverage Volume91,993 shsMarket Capitalization$43.22 millionP/E RatioN/ADividend YieldN/ABeta2.56 ProfileChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, focuses on providing biometric data monitoring solutions in the United States. The company focuses to deliver remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It is developing Bioflux mobile cardiac telemetry solution that provides recurring reimbursements to doctors, hospitals, and independent diagnostic testing facilities; revenue model that fits within the established insurance billing practices; built-in cellular connectivity; and motion tracking to detect exercise, activity, and disorientation. The company is also developing Biolife, a health and lifestyle solution for individuals. It has a collaboration agreement with the University of Calgary to determine the predictive value of electrocardiogram readings in preventative healthcare applications. Biotricity, Inc. is based in Redwood City, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Biotricity. Previous Next 2.4 Community Rank Outperform VotesBiotricity has received 57 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBiotricity has received 64 “underperform” votes. (Add your “underperform” vote.)Community SentimentBiotricity has received 52.89% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Biotricity and other stocks. Vote “Outperform” if you believe BTCY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BTCY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldBiotricity does not currently pay a dividend.Dividend GrowthBiotricity does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Biotricity insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.04% of the stock of Biotricity is held by institutions. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electric services Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BTCY Previous Symbol CUSIPN/A CIK1630113 WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares37,256,000Market Cap$43.22 million Next Earnings Date11/13/2020 (Estimated) OptionableNot Optionable $1.16 +0.09 (+8.41 %) (As of 09/24/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive BTCY News and Ratings via Email Sign-up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Biotricity (OTCMKTS:BTCY) Frequently Asked Questions How has Biotricity's stock price been impacted by COVID-19? Biotricity's stock was trading at $1.2250 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BTCY shares have decreased by 5.3% and is now trading at $1.16. View which stocks have been most impacted by COVID-19. When is Biotricity's next earnings date? Biotricity is scheduled to release its next quarterly earnings announcement on Friday, November 13th 2020. View our earnings forecast for Biotricity. How were Biotricity's earnings last quarter? Biotricity Inc (OTCMKTS:BTCY) released its earnings results on Friday, August, 14th. The company reported ($0.09) earnings per share for the quarter. The business earned $0.45 million during the quarter. View Biotricity's earnings history. Are investors shorting Biotricity? Biotricity saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 14,300 shares, an increase of 30.0% from the August 15th total of 11,000 shares. Based on an average daily trading volume, of 99,500 shares, the days-to-cover ratio is currently 0.1 days. View Biotricity's Short Interest. Who are some of Biotricity's key competitors? Some companies that are related to Biotricity include Empresa Distribuidora y Cmrz Nrt (EDN), Sky Solar (SKYS), AK PWR & TEL CO/SH SH (APTL), Summer Energy (SUME), Ocean Power Technologies (OPTT), Premier (PRHL), EnSync (ESNC), Aqua Power Systems (APSI), Commerce Energy Group (CMNR) and Nacel Energy (NCEN). View all competitors. What other stocks do shareholders of Biotricity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BIOLINERX LTD/S (BLRX), Canopy Growth (CGC), CV Sciences (CVSI) and Charlotte's Web (CWBHF). Who are Biotricity's key executives? Biotricity's management team includes the following people: Mr. Waqaas Al-Siddiq, Founder, Pres, CEO & Chairman (Age 34)Mr. John Ayanoglou, Chief Financial Officer (Age 53)Mr. Casey Shattuck, Global VP of SalesMr. Amir Ali, Chief Devel. OfficerMr. Spencer LaDow, VP of Engineering What is Biotricity's stock symbol? Biotricity trades on the OTCMKTS under the ticker symbol "BTCY." How do I buy shares of Biotricity? Shares of BTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Biotricity's stock price today? One share of BTCY stock can currently be purchased for approximately $1.16. How big of a company is Biotricity? Biotricity has a market capitalization of $43.22 million. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
